Advertisement

Loading...

Abbisko Cayman Limited

2256.HK•HKSE
Healthcare
Biotechnology
HK$13.05
HK$0.96(7.94%)
Hong Kong Market is Open • 11:49

Abbisko Cayman Limited (2256.HK) Stock Forecast & Price Predictions

Get the latest Abbisko Cayman Limited (2256.HK) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted PriceHK$14.27
Change↑ HK$1.22 (9.35%)

Quarterly Forecast

Predicted PriceHK$15.09
Change↑ HK$2.04 (15.63%)

Yearly Forecast

Predicted PriceHK$24.31
Change↑ HK$11.26 (86.25%)

3 Years Forecast

Predicted PriceHK$43.16
Change↑ HK$30.11 (230.75%)

5 Years Forecast

Predicted PriceHK$62.004
Change↑ HK$48.95 (375.13%)

7 Years Forecast

Predicted PriceHK$80.78
Change↑ HK$67.73 (519.03%)

Abbisko Cayman Limited Stock Forecast Summary

Abbisko Cayman Limited (2256.HK) stock is currently priced at $13.05. Based on Meyka AI predictions, the short-term outlook is bullish, with momentum pointing higher. The 1-month projection suggests a move toward $14.27.

In the long term, 2256.HK shows a bullish trend. The 2027 forecast points to $24.31 (86.25% change), while the 2031 forecast suggests $62.00 (375.13% change). Looking 7 years ahead, projections estimate the stock could trade near $80.78, a 519.03% change from today’s price.

Overall Sentiment

Bullish

Short-Term Outlook

Bullish

Long-Term Outlook

Bullish

This mix indicates that Abbisko Cayman Limited stock is expected to rise steadily over the coming years.

Abbisko Cayman Limited yearly Price Forecast Chart

Explore the yearly forecast chart for 2256.HK, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Abbisko Cayman Limited over different timeframes.

No forecast data available

No prediction data found for this time period.

empty-state-iconForecasting data is not available for 2256.HKForecasting details for 2256.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Abbisko Cayman Limited Stock Forecast 2026

The forecast for Abbisko Cayman Limited (2256.HK) in 2026 suggests a price of $24.31, representing a 86.25% move from today’s price.

Average Target: $24.31

Market Outlook: bullish based on current trend indicators.

Key Drivers in 2026:
  • Earnings growth projections.
  • Competitive performance in the Healthcare.
  • Macroeconomic factors such as interest rates and inflation.

Abbisko Cayman Limited Stock Forecast 2030

By 2030, Meyka AI projects 2256.HK could trade near $62.00, showing a potential 375.13% compared to current levels.

Average Target: $62.00

Market Outlook: bullish.

What could influence the 2030 forecast:
  • Technological innovation and product cycles.
  • Expansion into global markets.
  • Long-term investor sentiment toward Abbisko Cayman Limited.

Abbisko Cayman Limited 7-Year Stock Forecast (2032–2033)

Looking 7 years ahead, the long-term forecast for 2256.HK points to a price around $80.78, which is a projected 519.03% move from today’s level.

Average Target: $80.78

Outlook: bullish, depending on macroeconomic conditions and sector growth.

Long-Term Drivers:
  • Global economic expansion or contraction.
  • Regulatory and policy environment.
  • Abbisko Cayman Limited’s ability to maintain market leadership.

Frequently Asked Questions